A carregar...
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions
OBJECTIVE: To report on the incidence of nab-paclitaxel hypersensitivity reactions (HSRs) in patients with prior taxane HSR. METHODS: From 2005 to 2015, all patients who received nab-paclitaxel for a gynecologic malignancy were identified. Chart abstraction included pathology, prior therapy, indicat...
Na minha lista:
| Publicado no: | J Gynecol Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5447141/ https://ncbi.nlm.nih.gov/pubmed/28541630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2017.28.e38 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|